Type A - Calumet, Inc. (CLMT) 20260730 Stock Analysis

📅 Calumet Key Upcoming Events

• August 7, 2026 Second Quarter 2026 Earnings Release
  • Description: Calumet is scheduled to release its Q2 2026 financial results before the market opens. This report will be highly scrutinized as it represents the first full quarter of operations following the completion of the MaxSAF 150 expansion and the resumption of operations at the Shreveport facility following the organic chloride outage.
• December 31, 2027 Expiration of the 45Z Clean Fuel Production Credit
  • Description: The current legislative framework under the Inflation Reduction Act designates the expiration of the 45Z tax credit at the end of 2027. Legislative efforts to extend this critical subsidy for sustainable aviation fuel (SAF) through 2029 are ongoing and represent a massive binary outcome for the profitability of Montana Renewables.
• First Half of 2028 Target for MaxSAF 300 Expansion
  • Description: Calumet aims to utilize the delayed-draw portion of its $1.44 billion Department of Energy (DOE) loan guarantee to double SAF capacity to 300 million gallons annually, positioning the company as the dominant SAF producer in the Western Hemisphere.

🏢 Step 1: Calumet Company Overview & Business Model

Q1-A1. What is Calumet?

• Company Name (Ticker): Calumet, Inc. (CLMT)
• Sector: Energy
• Exchange: NASDAQ
• Founded: 1916
• Listing Date: January 30, 2006 (as an MLP), Corporate Conversion completed July 10, 2024
• Fiscal Year End: December
• Headquarters: Indianapolis, Indiana, United States
• CEO: Louis Todd Borgmann
• Market Cap: $3.60B
• Shares Outstanding: 87.15M
• Current Stock Price: $41.28
• Annual Dividend Yield: ➖ Not applicable
• Ex-dividend Date: ➖ Not applicable
• As-of: July 30, 2026 (ET)

Q1-A2. How Does Calumet Make Money?

• Calumet operates a highly bifurcated business model. On one side, it functions as a highly specialized refiner, processing crude oil into a diverse array of customized lubricating oils, white oils, solvents, waxes, and asphalt. These specialty products are sold to thousands of global customers who utilize them as essential raw components in industrial applications, cosmetics, and consumer goods. On the other side, through its Montana Renewables, LLC (MRL) subsidiary, Calumet acts as a premier producer of sustainable aviation fuel (SAF) and renewable diesel, processing agricultural and waste feedstocks (like tallow and canola oil) into premium, low-carbon fuels that command significant regulatory and market premiums.

Q1-A3. Calumet’s Revenue Segments & Core Income Sources

• The enterprise generates revenue through three distinct operational segments, each with vastly different margin profiles and capital requirements.
• Specialty Products and Solutions (SPS): This represents the traditional cash engine of the company. The SPS segment produces lubricating oils, solvents, and waxes. In Q1 2026, despite a severe operational outage, this segment produced 55,621 barrels per day (bpd) and generated $44.3 million in Adjusted EBITDA. This segment benefits from highly inelastic demand, allowing the company to rapidly pass through feedstock cost inflation to end consumers.
• Montana/Renewables (MR): This segment represents the core growth catalyst. Located in Great Falls, Montana, the facility processes renewable feedstocks into SAF, renewable diesel, and renewable hydrogen. While it generated $10.2 million in Adjusted EBITDA with Tax Attributes in Q1 2026 (constrained by turnaround downtime), the segment recently expanded its SAF capacity to 150 million gallons annually (MaxSAF 150) and is targeting 300 million gallons by 2028. This segment operates under a heavily subsidized regulatory umbrella, capitalizing on the federal 45Z Clean Fuel Production Credit and state-level Low Carbon Fuel Standard (LCFS) premiums.
• Performance Brands (PB): Operating as a high-performance retail arm, this segment blends and markets products under the Royal Purple, Bel-Ray, and TruFuel brands. Following the sale of the industrial portion of Royal Purple for $110 million in early 2025, the segment is entirely consumer-facing, generating $12.6 million in Adjusted EBITDA in Q1 2026.

Q1-A4. Who Are Calumet’s Competitors?

• The competitive ecosystem surrounding Calumet is fragmented due to the company’s dual identity as a specialty chemicals producer and a renewable fuels pioneer.
• Traditional Refining Peers: In the conventional fuels and specialty asphalt space, Calumet competes with mid-cap independent refiners such as Delek US Holdings, Inc. (DK), CVR Energy, Inc. (CVI), Par Pacific Holdings, Inc. (PARR), and HF Sinclair Corporation (DINO). Calumet’s SPS segment generally commands higher structural margins than these pure-play refiners because specialty chemicals are less tethered to the extreme volatility of the benchmark crack spread.
• Renewable Fuels Competitors: In the SAF and renewable diesel sector, Montana Renewables competes directly with massive joint ventures and energy majors. Key rivals include Diamond Green Diesel (a joint venture between Valero and Darling Ingredients), Neste Oyj, World Energy, and Phillips 66’s Rodeo facility. MRL maintains a competitive advantage through its geographic isolation in the Pacific Northwest, granting it superior access to cost-advantaged Canadian feedstocks and direct rail routes to premium West Coast LCFS markets.

Q1-A5. Calumet Key Events: Past 12 Months

• July 10, 2024 Corporate Conversion Completed
  • Description: Calumet successfully converted from a Master Limited Partnership (MLP) to a C-Corporation, exchanging all common units into shares of common stock. This structural overhaul allowed the company to attract institutional capital previously restricted by MLP tax complexities.
• February 18, 2025 First Drawdown of $1.44 Billion DOE Loan
  • Description: Montana Renewables received its first drawdown of $782 million from the U.S. Department of Energy. This non-recourse capital was utilized to retire expensive legacy mezzanine debt, instantly unlocking approximately $80 million in annual free cash flow.
• March 2025 Divestiture of Royal Purple Industrial Business
  • Description: The company divested the industrial assets of its Royal Purple brand to Lubrication Engineers for $110 million, directing the proceeds toward the reduction of restricted group debt.
• August 22, 2025 EPA Grants Small Refinery Exemptions
  • Description: Calumet secured full or partial exemptions from the EPA for Renewable Identification Number (RIN) obligations from 2019 to 2024. This reduced the company’s accrued balance sheet liability from 396 million RINs down to 89 million RINs, lifting a massive regulatory overhang.
• January 2026 Issuance of $405 Million Senior Notes to Retire Near-Term Debt
  • Description: Calumet issued 9.75% Senior Notes due 2031. The proceeds were used to entirely retire the company’s impending 2026 and 2027 maturity wall, securing a stable runway for the execution of the MaxSAF expansion.
• March 2026 Shreveport Organic Chloride Contamination Outage
  • Description: An unplanned outage at the Shreveport facility, caused by organic chloride contamination in the crude supply, resulted in a loss of 750,000 barrels of production and an estimated $30 million opportunity cost in Q1 2026.
• May 2026 Completion of MaxSAF 150 Expansion
  • Description: Montana Renewables successfully completed a planned turnaround, integrating the MaxSAF 150 expansion to increase sustainable aviation fuel capacity to 120-150 million gallons annually. Management confirmed that 100 million gallons of this new capacity are already locked into premium offtake agreements.

Q1-A6. Step 1 Key Takeaways

• Step 1 Summary: Calumet has aggressively restructured its capital and operating framework over the past 24 months, successfully extending its maturity wall to 2031 while transitioning from a legacy specialty refiner into a leading sustainable aviation fuel producer backed by a $1.44 billion DOE loan. The enterprise is poised for a massive free cash flow inflection in late 2026, provided it can navigate residual regulatory volatility and execute its SAF capacity scale-up.
• Top 3 Red Flags:
  • 1 Structural net-short exposure to Renewable Identification Numbers (RINs), which generated a $115.9 million non-cash mark-to-market loss in Q1 2026 as liabilities swelled to $316.7 million.
  • 2 Severe operational vulnerability to crude supply contaminants, evidenced by the $30 million opportunity cost incurred from organic chloride damage at the Shreveport facility.
  • 3 An aggressively leveraged balance sheet with $2.33 billion in total debt and negative stockholders’ equity of $1.04 billion.
• Top 5 Key Financial/Operational Indicators for Next-Level Analysis:
  • 1 Adjusted EBITDA with Tax Attributes (to filter out non-cash RINs and derivative volatility).
  • 2 Montana Renewables SAF production run rate and capacity utilization.
  • 3 Specialty Products Material Margin ($/bbl).
  • 4 Spot prices for D4 and D6 RINs and the federal 45Z Clean Fuel Production Credit value.
  • 5 Free cash flow generation within the restricted group.
• Top 3 Unconfirmed and Estimated:
  • 1 The timeline and exact capital requirements for the buyout of Warburg Pincus’s $250 million preferred equity stake in Montana Renewables.
  • 2 The ultimate political fate of the 45Z tax credit, which is currently slated to expire at the end of 2027.
  • 3 The final design and margin impact of the EPA’s 2028 Renewable Volume Obligations.

🏰 Step 2: Calumet’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Calumet Have a Durable Economic Moat?

• Entry barriers: Calumet possesses a narrow but highly durable economic moat rooted in intangible assets, high switching costs, and regulatory positioning. In the Specialty Products segment, the company formulates highly customized lubricants and waxes that are deeply embedded into the manufacturing processes of consumer and industrial brands. Transitioning away from Calumet’s formulations requires customers to undergo expensive, time-consuming recertification processes. On the renewables side, the MaxSAF facility constitutes a massive physical barrier to entry. The $1.44 billion DOE loan serves as a government-sponsored moat, providing subsidized capital that new entrants cannot easily replicate in a high-interest-rate environment.
• Pricing Power: The company exhibits extraordinary pricing power in its SPS segment. During a two-week period in March 2026, when crude oil feedstock prices spiked by over 50%, Calumet’s commercial team executed more than 20 distinct price increases across its product lines. This aggressive strategy successfully defended a robust specialty material margin of approximately $54 per barrel, proving the inelasticity of customer demand even amidst severe inflation.
• Profitability Defense: While legacy refining margins are inherently cyclical, Calumet defends its profitability through long-term SAF offtake agreements. Management has secured multi-year, evergreen contracts for roughly 100 million gallons of MaxSAF production, locking in structural premiums of $1.00 to $2.00 per gallon over standard renewable diesel. This contractual framework immunizes a significant portion of cash flow from underlying commodity volatility.

Q2-A2. Is Calumet’s Growth Sustainable?

• Industry Structure and Growth Outlook: The sustainable aviation fuel sector is experiencing parabolic growth. Driven by corporate net-zero commitments and stringent government blending mandates (such as those in the EU and UK), the global SAF market is projected to expand at a 27.5% CAGR, growing from $2.37 billion in 2026 to $10.27 billion by 2032. The aviation industry fundamentally requires drop-in liquid fuels because electrification and hydrogen propulsion remain technologically unviable for long-haul commercial flight.
• Growth Sustainability: Calumet’s growth is heavily subsidized and structurally sound, but it is contingent upon policy continuity. The company’s expansion from 30 million gallons to 150 million gallons (and eventually 300 million gallons) of SAF is underwritten by the federal 45Z Clean Fuel Production Credit, which rewards low carbon intensity (CI) fuels.
  • Downside Scenario 1: A repeal or expiration of the 45Z tax credit at the end of 2027 would instantly compress SAF margins, rendering the fuel uncompetitive with traditional Jet-A.
  • Downside Scenario 2: A systemic shortage of ultra-low CI lipid feedstocks (tallow, used cooking oil) could invert the feedstock-to-fuel margin spread, crippling EBITDA generation.
  • Downside Scenario 3: Protracted operational failures, akin to the Shreveport organic chloride contamination, could repeatedly stall production momentum and drain the liquidity required to service the $2.33 billion debt load.

Q2-A3. How Does Calumet Allocate Capital & Return Cash?

• Reinvestment and Debt Reduction Priorities: Management exercises extreme discipline regarding capital allocation, directing all available liquidity toward deleveraging and high-return infrastructure projects. The company does not currently pay a dividend, nor does it execute share repurchases. The primary use of capital over the past 24 months has been the execution of the MaxSAF expansion and the strategic elimination of near-term debt.
• Capital Efficiency: Calumet has demonstrated elite capital efficiency in its MaxSAF 150 scale-up. Originally estimated to cost between $150 million and $250 million, engineers optimized the facility’s existing metallurgy to achieve the 150-million-gallon capacity for a mere $20 million to $30 million. Furthermore, by utilizing the $782 million Tranche 1 of the DOE loan to retire expensive third-party mezzanine debt held by Stonebriar, management unlocked $80 million in annual free cash flow. However, shareholder returns are strictly deferred until the $2.3 billion debt load is normalized and the restrictive covenants on the 2028, 2029, and 2031 notes are alleviated.

Q2-A4. Step 2 Key Takeaways

• 📊 Step 2 Score: 23 pts/25 pts (Economic Moat 9/10 pts + Growth Sustainability 7/8 pts + Capital Allocation 7/7 pts)
• Scoring Rationale:
  • Economic Moat (9/10): Exceptional pricing power demonstrated by the ability to pass through a 50% feedstock cost spike in real-time, fortified by highly integrated specialty formulations.
  • Growth Sustainability (7/8): SAF demand represents a secular supercycle backed by aviation mandates, though the reliance on expiring 45Z tax subsidies presents a long-term regulatory tail risk.
  • Capital Allocation (7/7): Flawless execution of the DOE loan to eliminate 14% cost-of-capital debt, paired with brilliant engineering that slashed MaxSAF expansion capex by nearly 90%.
• Step 2 Summary: Calumet commands a deeply entrenched, narrow moat in specialty chemicals and is aggressively capturing first-mover advantage in the hyper-growth sustainable aviation fuel market. Capital allocation is exceptionally disciplined, strictly prioritizing balance sheet repair and high-return, subsidized infrastructure expansions over premature shareholder returns.

💰 Step 3: Is Calumet Profitable? Financial Health Analysis

Q3-A1. Calumet’s Growth & Profitability Trends

• Financial Performance: Calumet’s GAAP financial metrics are highly distorted by non-cash regulatory and hedging mechanics. For the fiscal year 2025, the company reported a net loss of $33.8 million on $4.1 billion in revenue, a vast improvement from the $222.0 million net loss in 2024. However, analyzing Adjusted EBITDA with Tax Attributes reveals the true underlying profitability. This metric surged 28% year-over-year to $293.3 million in 2025, driven by $100 million in structural cost reductions and record production in both the SPS and MR segments.
• Leverage and Margins: The first quarter of 2026 highlighted extreme volatility. The company posted a GAAP net loss of $317.0 million, severely impacted by a $115.9 million mark-to-market loss on RINs, $102.7 million in unrealized derivative losses, and $37.9 million in stock-based compensation triggered by the soaring share price. Filtering out these non-cash distortions, Adjusted EBITDA with Tax Attributes stood at $50.1 million. Operating leverage is currently masked by these accounting adjustments and the $30 million opportunity cost associated with the Q1 Shreveport outage.

Q3-A2. How Profitable Is Calumet? (Margins & ROIC)

• Calumet’s return on invested capital (ROIC) historically oscillates between negative and low single digits, heavily weighed down by legacy debt interest and the capital-intensive nature of the Montana Renewables buildout. The normalized Return on Assets (ROA) stands at approximately -4.86%, while the normalized ROIC is cited at -0.23%. However, these trailing metrics fail to capture the forward-looking economics of the MaxSAF expansion. The legacy refining operations are notoriously cyclical, but the integration of SAF production—commanding $1.00 to $2.00 per gallon premiums over standard renewable diesel—is engineered to structurally elevate corporate ROIC above the company’s estimated Weighted Average Cost of Capital (WACC) once steady-state operations commence in late 2026. Compared to independent refining peers, Calumet’s gross margin profile (approximately 6.13%) remains highly compressed by raw material costs and RIN expenses.

Q3-A3. What Drives Calumet’s Returns? (ROIC Breakdown)

• Industry-specific efficiency analysis: For a complex refiner transitioning to renewable fuels, the core efficiency driver is the “Specialty Material Margin” and the “SAF Premium.”
• In the SPS segment, Calumet consistently generates a material margin of $50 to $60 per barrel, vastly outperforming the commodity crack spreads that govern pure-play fuel refiners. This stability allows the company to absorb fixed costs effectively.
• In the Montana Renewables segment, the critical efficiency metric is the production cost per gallon relative to the value of generated environmental credits (RINs, LCFS, and 45Z). MRL successfully drove its operational cost target down to approximately $0.41 to $0.70 per gallon. By aggressively minimizing processing costs while maximizing the extraction of Section 45Z tax credits—which reward lower carbon intensity—Calumet can synthetically inflate its ROIC without requiring an increase in the underlying wholesale price of the physical fuel.

Q3-A4. Are Calumet’s Earnings High Quality?

• Calumet’s earnings quality is currently poor due to massive divergences between GAAP net income and operating cash flow (OCF). In Q1 2026, the company reported a net loss of $317.0 million, while net cash used in operating activities was an outflow of $86.2 million.
• The primary culprits for this discrepancy are wild swings in non-cash items: massive mark-to-market adjustments on RIN liabilities, unrealized losses on derivative instruments used to hedge inventory, and stock-based compensation. Because the company relies heavily on Supply and Offtake inventory financing arrangements, standard cash conversion cycles are obfuscated. The trend over the past three years shows a company generating sufficient Adjusted EBITDA to cover cash interest, but struggling to convert that into unencumbered free cash flow due to the relentless capital demands of the renewables transition.

Q3-A5. Is Calumet’s Balance Sheet Healthy? (Debt & Leverage)

• Calumet’s balance sheet is highly leveraged and intensely fragile. As of March 31, 2026, total debt stood at a staggering $2.33 billion. This resulted in negative stockholders’ equity of $1.04 billion.
• Refinancing and Liquidity: Management has aggressively addressed the immediate refinancing risks. In January 2026, Calumet issued $405 million of 9.75% Senior Notes due 2031 to completely retire the impending 2026 and 2027 maturity wall. Concurrently, the DOE loan ($825.2 million outstanding as of Q1 2026) is non-recourse to the parent, meaning it is secured solely by MRL assets, protecting the broader corporation from default contagion. While liquidity is currently sufficient (with $178.6 million in cash and restricted cash), the immense interest burden and the highly restrictive covenants on the 2028, 2029, and 2031 notes dictate that the company must flawlessly execute the MaxSAF scale-up to prevent a future liquidity crisis.

Q3-A6. Step 3 Key Takeaways

• 📊 Step 3 Score: 13 pts / 25 pts (Profitability·Capital Efficiency 6/10 pts + Cash Flow·Profit Quality 3/8 pts + Financial Soundness·Debt Management 4/7 pts)
• Scoring Rationale:
  • Profitability·Capital Efficiency (6/10): Underlying EBITDA generation is robust, driven by $100M in cost cuts and high specialty margins, but legacy debt interest brutally suppresses absolute ROIC and ROA.
  • Cash Flow·Profit Quality (3/8): Massive non-cash distortions from RIN mark-to-market accounting and derivative swings severely obscure actual operating cash generation, evidenced by the $86.2M Q1 OCF burn.
  • Financial Soundness·Debt Management (4/7): Management brilliantly eliminated the near-term maturity wall and isolated risk via the non-recourse DOE loan, but carrying $2.33B in debt against negative $1.04B in equity leaves zero margin for error.
• Step 3 Summary: Calumet is operating on a financial tightrope. The underlying asset base generates highly competitive unit-level margins, but the enterprise’s cash flow is relentlessly consumed by a staggering debt burden and immense working capital volatility tied to environmental regulatory compliance.

🔎 Step 4: Calumet Forensic Accounting & Dilution Review

Q4-A1. Does Calumet Have Accounting Red Flags?

• Revenue recognition: not found
  • Evidence: The company applies standard ASC 606 revenue recognition across its segments upon the transfer of control of physical commodities, with no historical restatements related to top-line recognition manipulation.
• Cost capitalization: not found
  • Evidence: Capitalization of turnaround costs and construction interest (such as the $232.8 million allowable under the DOE loan facility) follows standard GAAP protocols for heavy refining infrastructure.
• Sharp increase in accounts receivable and inventory: discovered
  • Evidence: In Q1 2026, the company reported $46.0 million in unrealized losses stemming from the increased value of inventory trapped within its Supply and Offtake inventory financing arrangement, driven by rapid crude price spikes.
• Non-recurring adjustment (normalization): discovered
  • Evidence: Management heavily relies on “Adjusted EBITDA with Tax Attributes,” which strips out massive non-cash RIN mark-to-market losses ($147.4M in Q1 2026) and unrealized derivative swings. While necessary for understanding run-rate cash generation, this non-GAAP metric requires intense investor scrutiny.

Q4-A2. Is Calumet Overspending? (Capex & Capital Cycle)

• Calumet operates in the highly capital-intensive refining and biofuels sector. However, the company has demonstrated extreme capital discipline rather than overspending. The MaxSAF 150 expansion was a masterclass in capital efficiency; by repurposing existing metallurgy rather than initiating a greenfield build, management reduced the required capital expenditure from an initial estimate of $150-$250 million down to just $20-$30 million. Furthermore, the massive $1.44 billion capital injection required for the broader Montana Renewables buildout is being funded by the heavily subsidized DOE loan guarantee rather than through predatory equity dilution or high-yield public debt. This suggests maximum restraint in a sector notorious for capex blowouts.

Q4-A3. How Sound Is Calumet’s Cash Flow?

• The soundness of Calumet’s cash flow is structurally compromised by environmental regulatory frameworks and working capital volatility. In Q1 2026, operating cash flow was a deeply negative $86.2 million. The primary driver of this cash bleed is the company’s structural short position in Renewable Identification Numbers (RINs). As an obligated party under the RFS, Calumet must purchase RINs to comply with blending mandates. When RIN spot prices spike, the company is forced to tie up significant liquidity in compliance purchases. Additionally, the company’s reliance on inventory intermediation agreements (Supply and Offtake) creates severe cash flow swings when underlying commodity prices experience rapid 50% price shocks, as witnessed in March 2026. Cash flow will not achieve true stability until Montana Renewables reaches its full 150-to-300 million gallon run rate, generating organic environmental credits to offset the legacy refinery’s deficit.

Q4-A4. Is Calumet Diluting Shareholders?

• ⏪ Confirmed (Past) Dilution: The most significant recent equity event was the July 2024 C-Corp conversion, which exchanged all outstanding MLP common units for corporate common stock. While this simplified the capital structure, the base share count stands at approximately 87.15 million.
• ⏩ Potential (Future) Dilution & Overhang: The paramount overhang is the $250 million preferred equity stake held by Warburg Pincus in the Montana Renewables subsidiary. While not directly dilutive to the parent company’s share count, this preferred equity demands strict Minimum Multiple of Invested Capital (MOIC) and Internal Rate of Return (IRR) hurdles upon exit. If MRL fails to generate sufficient cash to buy out Warburg Pincus, the private equity firm’s 14.2% stake could command a disproportionate share of the subsidiary’s ultimate enterprise value, functionally diluting the parent company’s economic interest.

Q4-A5. Data Integrity Check

• Period: TTM/Quarterly Standardization (Q1 2026 trailing basis) ➡ (Pass)
• Definition: Non-GAAP Adjusted EBITDA and RINs mark-to-market normalization verified against SEC 10-Q filings ➡ (Pass)
• Number of shares: 87.15 million outstanding verified via StockAnalysis and Q1 filings ➡ (Pass)
• Unit: Unified USD in millions/billions ➡ (Pass)
• Single Value Confirmation: ➡ (Pass)

Q4-A6. Step 4 Key Takeaways

• 📊 Step 4 Score: 12 pts / 20 pts (Accounting anomalies/distortion signals 4/8 pts + Cash flow warning signals 3/7 pts + Dilution factors 5/5 pts)
• Scoring Rationale:
  • Accounting anomalies/distortion signals (4/8): Heavy reliance on non-GAAP “Adjusted EBITDA with Tax Attributes” masks the brutal reality of GAAP net losses, though capitalization and revenue recognition protocols remain highly disciplined.
  • Cash flow warning signals (3/7): Q1 2026 OCF was deeply negative (-$86.2M), highlighting structural vulnerabilities to RINs pricing spikes and inventory financing margin calls.
  • Dilution factors (5/5): The C-Corp conversion was cleanly executed without massive equity dilution, and the capital-intensive MR expansion is funded by non-dilutive DOE debt rather than ATM equity offerings.
• Step 4 Summary: Calumet’s accounting is technically sound but phenomenally complex, clouded by mark-to-market derivatives, RIN liability adjustments, and inventory intermediation facilities. Cash flow remains highly unstable, deeply sensitive to regulatory whims and commodity shocks, though direct equity dilution risk is surprisingly low.

👔 Step 5: Calumet Management & Shareholder Alignment

Q5-A1. Can You Trust Calumet’s Management? (Guidance Track Record)

• CEO Todd Borgmann and his executive team have demonstrated a profound ability to execute complex, multi-year strategic transformations. Management laid out a highly ambitious roadmap in 2022: convert to a C-Corp, stand up a world-class renewable fuels facility, secure cheap government financing, and eliminate the near-term maturity wall. Over the past 24 months, they have systematically achieved every one of these milestones. The successful closing of the $1.44 billion DOE loan and the flawless execution of the MaxSAF 150 capacity expansion—completed on time and for a fraction of the original estimated cost—proves that leadership consistently under-promises and over-delivers on engineering and capital allocation targets. However, guidance regarding quarterly cash flow remains difficult to predict due to the inherently volatile nature of their regulatory and hedging environment.

Q5-A2. What Are Calumet Insiders Doing?

• Insider transaction data over the trailing 12 to 18 months reveals a pattern of programmatic selling by key executives and directors, primarily driven by the massive appreciation in the stock price. Independent Director Daniel Sajkowski sold 89,550 shares across early 2025 and 2026, executing sales at prices ranging from $12.66 to $36.16 under 10b5-1 trading plans. Former Independent Director Jennifer Straumins liquidated 500,000 shares in mid-2025, capturing proceeds of nearly $7.4 million. Senior VP and General Counsel Gregory Morical also executed multiple sales of 25,123 shares around $16.60. While the volume of insider selling is notable, the context is crucial: the stock has experienced a parabolic 143% surge over the trailing 12 months, and these liquidations represent standard profit-taking and diversification following years of holding deeply depressed equity during the company’s turnaround phase.

Q5-A3. Is Calumet’s Management Aligned With Shareholders?

• Calumet’s compensation structure was drastically overhauled in 2025 to ensure airtight alignment between executive incentives and long-term shareholder value creation. The CEO’s pay is heavily at risk, with the annual incentive plan tied 60% to Adjusted EBITDA with Tax Attributes and 40% to stringent operational and safety metrics, all subject to a hard free cash flow threshold. Furthermore, long-term incentive awards are delivered 50% in time-based restricted stock units and 50% in performance share units (PSUs). Crucially, these PSUs vest based on a Relative Total Shareholder Return (TSR) metric measured over a three-year period (2025–2027) against the S&P SmallCap 600 Index. This structure guarantees that executives only capture maximum wealth if they consistently outperform the broader market, directly linking management’s financial destiny to the success of the MaxSAF scale-up.

Q5-A4. Step 5 Key Takeaways

• 📊 Step 5 Score: 11 pts / 15 pts (Management Trust 5/5 pts + Insider Trends 2/5 pts + Governance & Compensation System 4/5 pts)
• Scoring Rationale:
  • Management Trust (5/5): Flawless execution of complex strategic mandates—including the C-Corp conversion, DOE loan closing, and ultra-cheap MaxSAF engineering optimizations—builds immense credibility.
  • Insider Trends (2/5): Sustained, high-volume selling by directors (Sajkowski, Straumins) and executives into the stock’s massive rally indicates a desire to de-risk personal portfolios, slightly dampening confidence.
  • Governance & Compensation System (4/5): Overhauled compensation explicitly ties 50% of long-term incentives to Relative TSR and annual bonuses to hard cash flow thresholds, ensuring tight shareholder alignment.
• Step 5 Summary: Calumet’s leadership has masterfully orchestrated one of the most complex corporate turnarounds in the energy sector. While insiders have aggressively taken profits following the stock’s parabolic ascent, the structurally sound, TSR-linked compensation packages guarantee that management remains heavily incentivized to execute the final stages of the Montana Renewables expansion.

⛵ Step 6: Calumet Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Calumet Guidance

• Wall Street sentiment surrounding Calumet is overwhelmingly constructive, yet analyst models struggle to keep pace with the stock’s rapid appreciation. The average 12-month analyst consensus target price sits at $38.80, with a bullish high of $60.00 (H.C. Wainwright) and a bearish low of $26.00. With the stock currently trading at $41.28, the equity is functionally trading at a 6.4% to 12.8% premium to the street’s average consensus. This guidance gap indicates that institutional buyers are front-running traditional analyst models, aggressively pricing in the expected free cash flow inflection from the MaxSAF 150 rollout and the $80 million annual interest savings generated by the DOE loan. Analysts note that the company’s EBITDA projections for 2026 are heavily dependent on the EPA’s finalized SET2 mandates and the successful stabilization of 45Z tax credit regulations.

Q6-A2. What Is Calumet’s Short Interest?

• The market mechanics reveal a tense battleground. Calumet possesses a moderate but significant short interest, with 4.29 million shares sold short, representing approximately 7.35% of the tradable float. With an average daily trading volume of roughly 1 million shares, the short interest ratio equates to roughly 2.94 days-to-cover.
• Institutional ownership is robust, controlling approximately 50.05% to 59.61% of the outstanding equity, led by The Heritage Group (16.67%) and Two Seas Global Fund (8.01%). The presence of a 7.35% short float against a backdrop of heavily concentrated institutional and insider ownership creates the structural preconditions for moderate short-squeeze volatility, particularly if the company reports an unexpected EBITDA beat driven by surging SAF premiums.

Q6-A3. Step 6 Key Takeaways

• 📊 Step 6 Score: 3 pts / 5 pts (Consensus vs Guidance 1/3 pts + Supply/Short Interest 2/2 pts)
• Scoring Rationale:
  • Consensus vs Guidance (1/3): The stock price has outrun the average analyst target ($41.28 current vs. $38.80 consensus), indicating the equity is priced for perfection and highly vulnerable to any operational misstep that causes a guidance downgrade.
  • Supply/Short Interest (2/2): Concentrated institutional ownership (over 50%) paired with a 7.35% short interest float provides strong foundational support and the potential for squeeze momentum upon positive regulatory news.
• Step 6 Summary: Market sentiment is aggressively bullish, with investors looking past massive GAAP net losses and pricing in the utopian execution of the SAF expansion. This exuberance leaves the stock technically stretched above consensus targets, demanding flawless quarterly execution to maintain its current trajectory.

🚀 Step 7: Calumet Catalysts & Price Triggers

Q7-A1. What Could Move Calumet Stock? (Top 3 Catalysts)

• 1 Full realization of MaxSAF 150 production run rates
  • Timing: Next 3-6 months
  • Success Conditions: The Montana Renewables facility smoothly ramps up to its 150-million-gallon annualized capacity without metallurgical failures, successfully delivering product to the 100 million gallons of contracted premium offtakers.
  • Failure Risk: Operational bottlenecks or feedstock supply chain disruptions limit throughput, failing to generate the cash required to service the debt or buy out Warburg Pincus.
• 2 Structural expansion of EPA SET2 Renewable Volume Obligations (RVOs)
  • Timing: Next 6-12 months
  • Success Conditions: The EPA finalizes robust, multi-year mandates for advanced biofuels, placing a high structural floor under RIN prices and guaranteeing elevated baseline demand for SAF and renewable diesel.
  • Failure Risk: Political pressure or legal challenges force the EPA to grant sweeping new Small Refinery Exemptions (SREs), crashing RIN values and destroying MRL’s margin premium.
• 3 Aggressive deleveraging via Tranche 1 DOE Loan cash flow unlocking
  • Timing: Next 6-12 months
  • Success Conditions: The elimination of expensive legacy Stonebriar debt reliably yields the projected $80 million in unencumbered annual free cash flow, which management immediately directs toward restricted group debt paydown.
  • Failure Risk: The $80 million cash flow gain is entirely offset by surging feedstock lipid costs, trapping the parent company in a high-leverage holding pattern.

Q7-A2. Calumet’s Earnings Revision Trend

• Analyst earnings revisions have exhibited extreme volatility over the past 90 days, reflecting the complex, non-cash distortions dominating Calumet’s income statement. The consensus EPS estimates for upcoming quarters have seen significant downward revisions—some estimates downgraded to an expected $0.40 to $0.79 loss per share—driven primarily by the massive, unpredictable mark-to-market losses on RIN liabilities and hedging derivatives. However, analysts remain highly constructive on the top line, with revenue estimates for FY 2026 increasing by roughly 10.79%. This split—downward EPS revisions due to accounting noise paired with strong revenue and EBITDA momentum—forces the market to disregard traditional EPS metrics entirely in favor of SOTP cash flow analysis.

Q7-A3. Step 7 Key Takeaways

• 📊 Step 7 Score: 8 pts / 10 pts (Catalyst 7/7 pts + EPS Trend 1/3 pts)
• Scoring Rationale:
  • Catalyst (7/7): The combination of the MaxSAF 150 ramp, guaranteed $1-$2/gal contractual SAF premiums, and EPA RVO mandates provides a massive, highly visible engine for enterprise value expansion.
  • EPS Trend (1/3): Heavy downward revisions to GAAP EPS estimates—driven by non-cash RINs and derivative accounting chaos—create negative headline optics that may deter algorithmic and passive investors.
• Step 7 Summary: Calumet possesses some of the most explosive fundamental catalysts in the mid-cap energy sector. The successful ramp-up of the fully funded SAF expansion will fundamentally permanently alter the cash generation profile of the company, provided investors can stomach the violent, non-cash EPS volatility inherent in the transition.

⚖️ Step 8: Is Calumet Fairly Valued? Valuation Analysis

Q8-A1. Calumet’s Key Valuation Multiples (P/E, EV/EBITDA)

• Price/Sales: 0.86x (undervalued)
• P/E Ratio: Negative/-19.00x (Very Overvalued)
• Price/Cash Flow: 22.98x (Overvalued)
• Price/Book: Negative (Very Overvalued)
• EV/EBITDA Ratio: Not Meaningful/Negative trailing due to derivative losses (Very Overvalued)
• Scoring Rationale: Trailing absolute metrics are deeply distorted by the massive Q1 2026 GAAP net loss ($317M) and deeply negative equity/book value. Taken purely mechanically at the absolute trailing level, the equity screens as highly distressed and expensive relative to its current negative cash flows.
• 📌 (1) Axis Q8-A1 Score: -3

Q8-A2. Calumet vs Peers: Valuation Comparison

• Multiple selection based on peer comparison: Price / LTM Sales
  • Reasoning for alternative multiple: Forward PER and EV/EBITDA are severely distorted by Calumet’s massive non-cash RIN mark-to-market losses and derivative swings in the trailing periods, rendering them negative or non-comparable. Price to Sales offers the clearest benchmark against peers.
• Calculation of peer-to-peer deviation rate: -38.5%
  • 🧮 Calculation Formula: ((0.86x (CLMT) - 1.4x (Peer Mean)) / 1.4x (Peer Mean)) × 100 = -38.5%
• Scoring Rationale: Compared to a broad peer group of independent refiners (DK, DINO, PARR, CVI) that trade at an average Price/LTM Sales multiple of 1.4x, Calumet trades at a significant discount of 0.86x, reflecting the massive debt burden and the market’s discount on its volatile transition.
• 📌 (2) Axis Q8-A2 Score: +5

Q8-A3. Is Calumet Cheap or Expensive vs Its History?

• Comparison Indicators: Price/Sales (Trailing)
• Scoring Rationale: Over a 5-year historical band, Calumet’s P/S multiple has oscillated between 0.10x during peak distress and 0.86x currently. The stock is currently trading at the absolute peak of its 5-year historical valuation band, reflecting the aggressive market pricing of the MaxSAF future cash flows.
• 📌 (3) Axis Q8-A3 Score: -5

Q8-A4-1. What Growth Hurdle Does the Market Demand From Calumet? (Reverse DCF Alternative)

• Scoring Rationale: Reverse DCF is impossible due to highly volatile, negative trailing cash flows. Qualitatively, the market demands monumental execution. With the stock trading at 5-year highs and above analyst targets, the market requires flawless, immediate cash generation from the MaxSAF 150 expansion and a sustained $1.00-$2.00/gal SAF premium to justify the current $3.6B market cap. The growth difficulty is very high; any regulatory slip or operational outage will violently compress the multiple.
• 📌 (4) Axis Q8-A4-1 Score: -4

Q8-A5. Valuation Cross-Check

• Scoring Rationale:
  • (1) Axis Q8-A1 (Key Valuation Indicator): Overvalued
  • (2) Axis Q8-A2 (Peer-to-peer deviation rate): Very Undervalued
  • (3) Axis Q8-A3 (Historical Band Position): Very Overvalued
  • (4) Axis Q8-A4 (Justification for Growth): Very Overvalued
  • At least 3 of the 4 primary axes (A1, A3, and A4) agree on the direction (Overvalued). Therefore, the directional match condition is met and no penalty is applied.
• 📌 (5) Axis Q8-A5 Score: 0

Q8-A6. Calumet’s Asset & Stake Valuation

• Scoring Rationale: The SOTP valuation is heavily skewed by the underlying asset value of Montana Renewables. Considering the $1.44B DOE loan guarantee and Warburg Pincus injecting $250M for just a 14.2% stake in 2022 (implying a $1.76B valuation for MRL alone before the MaxSAF expansion), the intrinsic hidden value of the MRL subsidiary justifies a significant premium to the consolidated trailing metrics.
• 📌 (6) Axis Q8-A6 Score: +4

Q8-A7. Final Valuation Adjustment

• Scoring Rationale: An exceptional adjustment is mandated. Standard trailing multiples evaluate Calumet as a dying, debt-saddled legacy refiner, completely ignoring the structural reality that it has transitioned into one of the largest SAF producers on the continent. The $80M in guaranteed annual FCF unlocked by the DOE loan debt swap fundamentally alters the future solvency profile, requiring a strong positive adjustment to offset the backward-looking GAAP distortions.
• 📌 (7) Axis Q8-A7 Score: +5

Q8-A8. Valuation Adjustment Score Calculation

• Calculation Process:
  • (1) Axis (Key Valuation Indicators): -3 pts (Overvalued)
  • (2) Axis (Peer-to-peer deviation rate): +5 pts (-38.5% vs peers)
  • (3) Axis (Historical Band Position): -5 pts (Top 0-20%)
  • (4) Axis (Justification for Growth): -4 pts (Priced for perfection)
  • (5) Axis (Cross-Verification Adjustment): 0 pts (Conclusions agree)
  • (6) Axis (Held assets·Share Valuation): +4 pts (Warburg Pincus MRL valuation floor)
  • (7) Axis (Final adjustment): +5 pts (SOTP and DOE FCF unlock transition)
• 📊 Valuation adjustment score: A1 (-3) + A2 (+5) + A3 (-5) + A4 (-4) + A5 (0) + A6 (+4) + A7 (+5) = +2 pts
• Commentary: The mechanical valuation framework yields a slight positive score. The extreme absolute overvaluation caused by the recent 143% price surge and negative trailing GAAP earnings is counterbalanced by the massive, hidden intrinsic value of the Montana Renewables subsidiary, the peer-relative P/S discount, and the forward-looking cash flow unlock tied to the DOE loan.
• Step 8 Summary: The market has aggressively priced in the success of the turnaround. At $41.28, Calumet offers zero margin of safety on a trailing basis, meaning investors are entirely reliant on the future SOTP cash flows of the MaxSAF expansion to validate the current enterprise value.

💀 Step 9: What Are the Risks of Calumet? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Calumet?

• 1 45Z Tax Credit Expiration Cliff:
  • Cause: The Inflation Reduction Act’s 45Z Clean Fuel Production Credit, which provides up to $1.75/gallon for SAF, is currently scheduled to expire at the end of 2027.
  • Impact: Financial. If Congress fails to extend the credit, SAF margins will instantly compress, destroying the economic viability of the MaxSAF expansion and crippling MRL’s EBITDA generation.
  • Mitigation/Monitoring Indicators: Monitor legislative tracking of the “One Big Beautiful Bill Act” (OBBA) or broader tax-extender packages in Washington through late 2026.
• 2 Catastrophic Operational Outages (Organic Chlorides):
  • Cause: The accidental intake of contaminated feedstocks, such as the organic chloride contamination that paralyzed the Shreveport refinery in early 2026.
  • Impact: Financial. The Q1 2026 outage alone resulted in 750,000 barrels of lost production and a $30 million opportunity cost.
  • Mitigation/Monitoring Indicators: Monitor quarterly utilization rates and management commentary on feedstock testing protocols.
• 3 Structural Short-Squeeze in RIN Compliance Costs:
  • Cause: An unexpected spike in D6 and D4 RIN prices driven by EPA mandate hikes or systemic biofuel shortages.
  • Impact: Financial. Calumet holds a massive $316.7 million RIN obligation. A 20% spike in spot prices translates directly into tens of millions in non-cash mark-to-market losses and severe liquidity drains when physically settling the compliance deficit.
  • Mitigation/Monitoring Indicators: Track daily spot prices of D4/D6 RINs and the EPA’s annual Renewable Volume Obligation (RVO) publications.

Q9-A2. How Sensitive Is Calumet to the Economy?

• 1 Lipid Feedstock Commodity Spreads (⬇): The profitability of renewable diesel and SAF is hyper-sensitive to the price of tallow, used cooking oil, and canola oil. If agricultural yields crash, driving feedstock prices up faster than the finished fuel value, MRL’s margins will be squeezed to zero.
• 2 U.S. Interest Rates and Refinancing Costs (⬇): Carrying $2.33 billion in debt, Calumet is deeply exposed to a higher-for-longer rate environment. While they successfully pushed maturities to 2031, any need to tap the revolver or restructure the Warburg Pincus preferred equity at high rates would devour free cash flow.

Q9-A3. Calumet Pre-Mortem: What Could Go Wrong?

• 1 The Political Collapse of the Green Premium: A hostile shift in Washington results in the retroactive gutting of the EPA’s RFS mandates and a refusal to extend the 45Z tax credit. Without government subsidies, airlines refuse to pay the $1-$2 premium for SAF, reducing MRL to a stranded, multi-billion-dollar asset.
  • Early Warning Signal: Aggressive anti-ESG legislation passes the House and Senate, targeting IRA tax incentives for repeal.
• 2 The Debt Spiral: A prolonged recession crushes demand for specialty lubricants, slashing SPS segment EBITDA. Simultaneously, lipid feedstock prices spike, eroding MRL’s cash flow. Calumet begins bleeding cash, violates the covenants on its 2031 notes, and is forced into a highly dilutive, distressed debt restructuring.
  • Early Warning Signal: The Restricted Group’s free cash flow turns negative for two consecutive quarters, drawing down the remaining revolver capacity.
• 3 The Warburg Pincus Trap: MRL succeeds operationally, but not enough to meet the steep MOIC and IRR hurdles required to cleanly buy out Warburg Pincus. The private equity firm exercises its rights to force a liquidity event, resulting in the fire-sale of MRL and stripping the parent company of its crown jewel asset.
  • Early Warning Signal: Management’s timeline for the Warburg Pincus buyout is repeatedly delayed beyond 2027.

Q9-A4. Risk Adjustment Score Calculation

• 📊 Risk Adjustment Score: -14 pts
• Reason for Calculation: The deduction falls into the -11 to -20 range. The risks are not merely psychological; they are actively quantifying into severe financial hits, as evidenced by the $115.9M RIN mark-to-market loss and the $30M Shreveport outage in Q1 2026. The looming 2027 expiration of the 45Z tax credit represents a highly realistic threat that could inflict structural damage on the core business model within the next 12-18 months.
• Step 9 Summary: Calumet is a high-wire act. The upside is explosive, but the enterprise relies entirely on the persistence of federal tax subsidies, the flawless operation of complex refining metallurgy, and extreme capital discipline to manage a suffocating debt load.

🎯 Step 10: Calumet Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

• Investment Score & Rating: 58 pts (C Rating ⭐⭐)
  • Investment Score Calculation Formula:
    • Step breakdown: S2 (23) + S3 (13) + S4 (12) + S5 (11) + S6 (3) + S7 (8) = 70 pts
    • Steps 2-7 Sum (70 pts) + Valuation Adjustment (+2 pts) + Risk Adjustment (-14 pts) = Investment Score 58 pts
  • Commentary: The mechanical calculation exposes the brutal reality of Calumet’s current market position. While the strategic pivot to SAF and the execution of the DOE loan are masterful, the stock’s recent 143% surge has completely erased the valuation margin of safety. Combined with a crushing debt load, massive RIN liabilities, and the looming 45Z tax cliff, the risk-adjusted score firmly places the equity in highly speculative territory.

Q10-A2. Should You Buy Calumet? (Recommendation)

• Recommendation: Sell
  • Commentary: The equity is priced for an utterly flawless future that ignores the severe, ongoing cash-burn realities of the legacy business. With the stock trading above analyst consensus targets and vulnerable to massive headline EPS misses driven by RIN mark-to-market accounting, the risk/reward asymmetry is heavily skewed to the downside at current prices.

Q10-A3. Investment Thesis in One Line

• While Montana Renewables’ subsidized SAF expansion offers explosive SOTP upside, the parent company’s crippling $2.33B debt load and extreme exposure to volatile RIN liabilities make the equity too fragile at a 5-year valuation peak.

Q10-A4. Calumet’s Price Trend & Key Drivers

• Stock Price Trends Over the Past 12 Months: upward 📈
• February 18, 2025 DOE Loan Tranche 1 Drawdown ($782M)
  • Description: The successful unlocking of government capital to instantly retire expensive 14% Stonebriar debt validated the company’s financial engineering strategy, triggering a massive relief rally as bankruptcy risk was taken off the table. ➡ Stock Price Surge
• March 2026 EPA SET2 RVO Announcement
  • Description: The EPA finalized robust multi-year mandates for advanced biofuels, effectively placing a structural floor under the demand for MRL’s expanded SAF production. ➡ Stock Price Surge
• May 8, 2026 Q1 2026 Earnings Release (Shreveport Outage)
  • Description: The revelation of a $317 million GAAP net loss, driven by a $115.9 million RIN hit and a $30 million opportunity cost from the organic chloride outage, introduced severe volatility as retail investors recoiled at the headline cash burn. ➡ Stock Price Volatility

Q10-A5. Action Plan

• ⚠️ Since the Investment Score for the analyzed company is 58 pts and the Recommendation falls under Sell, this Action Plan section is omitted as the stock is not suitable for investment.

🕵️‍♂️ Deep Dive Analysis

• ⚠️ Since the Investment Score for the analyzed company is 58 pts and the Recommendation falls under Sell, this Deep Dive section is omitted as the stock is not suitable for investment.